Retreatment of nasopharyngeal carcinoma by intensity-modulated radiotherapy concurrent with weekly cetuximab

被引：0
|
作者：
Chua, D. T. T. [1 ]
Lee, V. [1 ]
Ng, S. [1 ]
机构：
[1] Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China
来源：
ORAL ONCOLOGY | 2009年
关键词：
D O I：
10.1016/j.oos.2009.06.514
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：196 / 196
页数：1
相关论文
共 50 条
  • [1] Efficacy of intensity-modulated radiotherapy with concurrent carboplatin in nasopharyngeal carcinoma
    Songthong, Anussara
    Chakkabat, Chakkapong
    Kannarunimit, Danita
    Lertbutsayanukul, Chawalit
    RADIOLOGY AND ONCOLOGY, 2015, 49 (02) : 155 - 162
  • [2] Efficacy of Intensity-Modulated Radiotherapy with concurrent carboplatin in nasopharyngeal carcinoma
    Songthong, A.
    Chakkabat, C.
    Kannarunimit, D.
    Lertbutsayanukul, C.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S28 - S29
  • [3] A phase II study of concurrent cetuximab-cisplatin and intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinoma
    Ma, B. B. Y.
    Kam, M. K. M.
    Leung, S. F.
    Hui, E. P.
    King, A. D.
    Chan, S. L.
    Mo, F.
    Loong, H.
    Yu, B. K. H.
    Ahuja, A.
    Chan, A. T. C.
    ANNALS OF ONCOLOGY, 2012, 23 (05) : 1287 - 1292
  • [4] Intensity-modulated radiotherapy alone compared with intensity-modulated radiotherapy plus concurrent chemotherapy in intermediate-risk nasopharyngeal carcinoma
    Liao, Shufang
    Zhang, Bin
    Su, Yixin
    Pan, Yufei
    Zhang, Jian
    Ye, Zhenkai
    Zhang, Rongjun
    Kong, Xiangyun
    Qin, Guanjie
    Mo, Yunyan
    Ruan, Xiaolan
    Liu, Jian
    Gan, Chunqiao
    Dai, Jinxuan
    Zhang, Ruyun
    Luo, Guanhong
    Liao, Xiaofei
    Jiang, Wei
    STRAHLENTHERAPIE UND ONKOLOGIE, 2024, 200 (10) : 867 - 875
  • [5] Reirradiation of nasopharyngeal carcinoma with intensity-modulated radiotherapy
    Chua, DTT
    Sham, JST
    Leung, LHT
    Au, GKH
    RADIOTHERAPY AND ONCOLOGY, 2005, 77 (03) : 290 - 294
  • [6] Cetuximab or nimotuzumab plus intensity-modulated radiotherapy versus cisplatin plus intensity-modulated radiotherapy for stage II-IVb nasopharyngeal carcinoma
    You, Rui
    Sun, Rui
    Hua, Yi-Jun
    Li, Chao-Feng
    Li, Ji-Bin
    Zou, Xiong
    Yang, Qi
    Liu, You-Ping
    Zhang, Yi-Nuan
    Yu, Tao
    Cao, Jing-Yu
    Zhang, Meng-Xia
    Jiang, Rou
    Mo, Hao-Yuan
    Guo, Ling
    Cao, Ka-Jia
    Lin, Ai-Hua
    Qian, Chao-Nan
    Sun, Ying
    Ma, Jun
    Chen, Ming-Yuan
    INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (06) : 1265 - 1276
  • [7] Experience of weekly cisplatin concurrent with intensity-modulated radiotherapy for locally advanced nasopharyngeal carcinoma patients with resistance to neoadjuvant chemotherapy
    Chen, Chuanben
    Chen, Taojun
    Huang, Chaoxiong
    Wang, Jing
    Fei, Zhaodong
    MEDICINE, 2017, 96 (44)
  • [8] Locoregionally advanced nasopharyngeal carcinoma treated with intensity-modulated radiotherapy plus concurrent weekly cisplatin with or without neoadjuvant chemotherapy
    Wee, Chan Woo
    Keam, Bhumsuk
    Heo, Dae Seog
    Sung, Myung-Whun
    Won, Tae-Bin
    Wu, Hong-Gyun
    RADIATION ONCOLOGY JOURNAL, 2015, 33 (02): : 98 - 108
  • [9] Concurrent nimotuzumab and intensity-modulated radiotherapy for elderly patients with locally advanced nasopharyngeal carcinoma
    Cao, Caineng
    Fang, Yuting
    Jiang, Feng
    Jin, Qifeng
    Jin, Ting
    Huang, Shuang
    Hu, Qiaoying
    Chen, Yuanyuan
    Piao, Yongfeng
    Hua, Yonghong
    Feng, Xinglai
    Chen, Xiaozhong
    CANCER SCIENCE, 2024, 115 (08) : 2729 - 2737
  • [10] Analysis of intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma
    Wu, Shihai
    Quan, Rencui
    Han, Ling
    Zhang, Huaqing
    Zhang, Baozhu
    Xu, Gang
    Li, Xianming
    MEDICINE, 2020, 99 (30) : E21325
12345